Based on the ROC curves for each dataset, the results (AUC> 0.7) of eight studies indicated that NR2F6 had a relatively high ability to differentiate between hepatoblastoma and non-cancer child livers (Figure 3). Here, NR2F6 is linked to hepatoblastoma.